Tempus AI Inc (NASDAQ:TEM) shares are surging Wednesday after the company announced a multi-year collaboration with AstraZeneca PLC (NASDAQ:AZN) and Pathos AI. read more
Tempus is an Illinois-based AI-enabled precision medicine firm that offers solutions such as data collaborations and biological modeling for the life sciences industry.